Erytech completes IPO

Erytech Pharma S.A., Lyon, France Business: Cancer, Endocrine/Metabolic, Hematology Date completed: 4/30/13 Type: IPO Raised: €16.7 million ($21.8 million) Shares: 1.4 million Price: €11.60 Shares aft...